Loading company…
Nivagen Pharmaceuticals makes and markets generic, specialty and sterile injectable drugs for healthcare providers in North America.
Founded in 2009 and based in Sacramento, US, Nivagen sells sterile injectables in IV bags, vials, pre-filled syringes and cartridges, along with 503B compounding services, mainly to hospitals, outpatient facilities and pharmacy networks in the United States and Canada. Its manufacturing facility is in California. In January 2026, PAI Pharma, a portfolio company of Olympus Partners, acquired the company from Telegraph Hill Partners. It raised USD 16 mn in May 2020 and is at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in